Prostate Cancer
Preclinical and clinical development of DNA vaccines for prostate cancer - Abstract
January 16, 2014
Improving outcome of surgical procedures is not possible without adequate quality measurement - Abstract
January 16, 2014
Deferred permanent prostate seed brachytherapy does not affect PSA outcome: Results from a large retrospective cohort - Abstract
January 16, 2014
Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival - Abstract
January 16, 2014
Long term rectal function after high-dose prostate cancer radiotherapy: Results from a prospective cohort study - Abstract
January 16, 2014
Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT) - Abstract
January 16, 2014
Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients - Abstract
January 16, 2014
A comparison of magnetic resonance spectroscopy and diffusion weighted imaging for diagnosing prostate cancer - Abstract
January 14, 2014
African American primary care physicians' prostate cancer screening practices - Abstract
January 14, 2014
Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens - Abstract
January 14, 2014
Effect of metastatic site on emergency department disposition in men with metastatic prostate cancer - Abstract
January 14, 2014